Quantcast

Alexion Pharma Issues Drug Recall for Soliris

Alexion Drug Recall for Soliris Intravenous Drug for Visible Particles Alexion Pharmaceuticals has issued a voluntary drug recall for certain lots of Soliris, a brand-name drug used to treat clotting disorders. The company said that the drug recall was related to a problem in the manufacturing process, which spurred a similar drug recall in November 2013.  Defective products and tainted drugs can be deadly. The nine lots that fall within the drug recall were reportedly shipped between June and October 2013, and have visible particulate … [Read more...]